<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Rotigotine; Neupro" /><meta name="IX" content="Rotigotine; Neupro" /><title>Neupro®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="129662.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="129662.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=129662.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2055.htm">4 Central nervous system</a> &gt; <a href="3631.htm">4.9 Drugs used in parkinsonism and related disorders</a> &gt; <a href="3632.htm">4.9.1 Dopaminergic drugs used in Parkinson’s disease</a> &gt; <a href="129827.htm">Dopamine-receptor agonists</a> &gt; <a href="129661.htm">ROTIGOTINE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="57171.htm" title="Previous: ROPINIROLE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="129828.htm" title="Next: Levodopa">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20807-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Rotigotine</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: R &gt; Interactions of Rotigotine</p></div></li></ul><ul><li><h3>British National Formulary (4)</h3></li><li><a href="129827.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Dopamine-receptor agonists</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease</p></div></li><li><a href="77550.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">PRAMIPEXOLE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease &gt; Dopamine-receptor agonists</p></div></li><li><a href="57171.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ROPINIROLE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 4 Central nervous system &gt; 4.9 Drugs used in parkinsonism and related disorders &gt; 4.9.1 Dopaminergic drugs used in Parkinson’s disease &gt; Dopamine-receptor agonists</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22rotigotine%22%22rotigotine%22%22restless+legs+syndrome%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0017s0143.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rotigotine Hydrochloride</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; R</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20807-c.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rotigotine</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antiparkinsonian Drugs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7000-a6-10-h.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Sleep-associated movement disorders</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Anxiolytic Sedatives Hypnotics and Antipsychotics &gt; Introduction &gt; Sleep disorders</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/10253.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Rotigotine</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; R &gt; RO</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E6E3E0R0D1256.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Rotigotine</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; R</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_129661">ROTIGOTINE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i1066.htm" title="Go to appendix 1">Rotigotine</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">Parkinson’s disease, either used alone or as adjunct to co-beneldopa
or co-careldopa; moderate to severe restless legs syndrome</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">see <a title="monograph-family: Dopamine receptor agonists" href="129827.htm#_129827">notes above</a>; ophthalmic testing recommended; avoid
exposure of patch to heat; withdraw gradually; <b>interactions:</b> Appendix 1 (rotigotine)</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">caution in severe impairment—no information available</p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">avoid—no information available</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">may suppress lactation; avoid—present in milk
in <i>animal</i> studies</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">see <a title="BNF:monograph-family: Dopamine receptor agonists" href="129827.htm#_129827">notes above</a>; also
constipation, dry mouth, dyspepsia, nausea, vomiting, weight changes;
hypertension, postural hypotension, palpitation, peripheral oedema;
hiccup; asthenia, dizziness, drowsiness (including <a title="BNF:target-block: Dopamine receptor agonists and driving" href="129827.htm#_213600">sudden onset of sleep</a>),
sleep disturbances, dyskinesia, hallucinations, headache, syncope,
sweating, rash, pruritus; <i>less commonly</i> abdominal
pain, atrial fibrillation, hypotension, confusion, paranoia, compulsive
behaviour (see <a title="BNF:target-text: Impulse control disorder caution" href="129827.htm#_211435">notes above</a>), erectile
dysfunction, and visual disturbances; <i>rarely</i> tachycardia,
seizures, irritability, obsessive compulsive disorder, and psychotic
disorder </p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Monotherapy in Parkinson’s disease, initially apply ‘2 mg/24
hours’ patch, increased in steps of 2 mg/24 hours at weekly intervals
if required; max. 8 mg/24 hours</p><p class="cR">Adjunctive therapy with levodopa in Parkinson’s disease, initially
apply ‘4 mg/24 hours’ patch, increased in steps of 2 mg/24 hours at
weekly intervals if required; max. 16 mg/24 hours</p><p class="cR">Restless legs syndrome, initially apply ‘1 mg/24 hours’ patch,
increased in steps of 1 mg/24 hours at weekly intervals if required;
max. 3 mg/24 hours</p><div class="cAR"><h3>Note</h3> <p class="cAX">Apply patch to dry, non-irritated skin on
torso, thigh, or upper arm, removing after 24 hours and siting replacement
patch on a different area (avoid using the same area for 14 days)</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li class="jN" id="_129662" style="margin: 0 0 0 20px;"><h1 class="title">Neupro®<span> (<a href="appendix-112803-U.htm#m315">UCB Pharma</a>)</span> <a href="204285.htm" title="Report adverse reaction(s)"><img class="cK" src="images/blacktri_s.png" alt="Black triangle" /></a> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Patches</span>, self-adhesive, beige, rotigotine
1 mg/24 hours, net price 28 = £77.24; 2 mg/24 hours, 28 = £77.24;
3 mg/24 hours, 28 = £97.48; 4 mg/24 hours, 28 = £117.71; 6 mg/24 hours,
28 = £142.79; 8 mg/24 hours, 28 = £142.79; 28-day starter pack of
7 × 2 mg/24 hours, 7 × 4 mg/24 hours, 7 × 6 mg/24 hours, and 7 × 8 mg/24
hours patches = £142.79. 10, counselling, driving, see <a title="BNF:target-block: Dopamine receptor agonists and driving" href="129827.htm#_213600">notes above</a><div class="cAQ"><div class="cAV"><h3>Note</h3> <p class="cAX">Remove patch (aluminium-containing) before
magnetic resonance imaging or cardioversion</p></div><div class="cAV"><h3>Note</h3> <p class="cAX">The <i><a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790">Scottish Medicines Consortium</a></i> has advised that <span class="cZ">Neupro</span>® is accepted as monotherapy
for the treatment of early-stage idiopathic Parkinson’s disease (June
2007) and for restricted use for the treatment of advanced Parkinson’s
disease in combination with levodopa where the transdermal route would
facilitate treatment (July 2007)</p></div><div class="cAV"><h3>Note</h3> <p class="cAX">The <i><a title="BNF:target-block: NICE and Scottish Medicines Consortium" href="29404.htm#_200790">Scottish Medicines Consortium</a></i> has advised (April 2009) that rotigotine (<span class="cZ">Neupro</span>®) is accepted for restricted use within NHS Scotland for the symptomatic
treatment of moderate to severe idiopathic restless legs syndrome
in adults with a baseline score of 15 points or more on the International
Restless Legs Scale</p></div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="57171.htm">Previous: ROPINIROLE</a> | <a class="top" href="129662.htm#">Top</a> | <a accesskey="]" href="129828.htm">Next: Levodopa</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>